Alterity Therapeutics annual operating expenses
2022
2023
2024
2025
2026
Alterity Therapeutics Operating Expenses Growth & History (ATHE)
Alterity Therapeutics's operating expenses was $25.1M for fiscal 2026.
View full Alterity Therapeutics company overviewAlterity Therapeutics annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-06-30 | $25.1M | $12.6M | +101.38% |
| 2025 | 2025-06-30 | $12.5M | −$7.2M | −36.48% |
| 2024 | 2024-06-30 | $19.6M | $5.0M | +33.87% |
| 2023 | 2023-06-30 | $14.7M | −$484,030 | −3.20% |
| 2022 | 2022-06-30 | $15.1M | — | — |
Alterity Therapeutics operating expenses trends
Between the periods ended 2022-06-30 and 2026-06-30, Alterity Therapeutics's operating expenses increased from $15.1M to $25.1M, a change of $10.0M.
About the metric
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
Calculation and source
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Alterity Therapeutics source filings ↗